Base Formation · 2026-06-25 · Pharmaceuticals & Drugs
EMCURE
Emcure Pharmaceuticals Ltd.
Watchlist-worthy setup
Setup readiness
Early Trend
- Pivot Levels
- ₹1748.3-1839.2
- Support Level
- ₹1708.0
- Resistance
- ₹2196.0
- Risk Distance
- 7.1% to stop
Reference levels for educational study only. Not a recommendation to buy or sell.
Swing Edge Intelligence
Structured setup analysis · research only
Setup status · Constructive setup
Structure shows workable momentum characteristics with selective risks to monitor.
Bullish factors
- Early breakout leg underway — monitor extension versus pivot.
- 1 prior pivot rejection in last 60d (-8 pts).
- ATR 3.5%/day — healthy volatility (+4).
- Action-ready zone: RS and pivot distance aligned (+5).
- BB squeeze — energy building.
- Extended +12%/10d — elevated stop risk (-10).
- Distribution pressure visible across recent sessions.
- Pocket pivot detected, but broader structure still shows distribution pressure.
- Recent volume expansion — institutional participation may be returning.
- Volume flow suggests quiet institutional accumulation.
Risk factors
Overall view
Localized accumulation signals (such as a pocket pivot) are present, but broader volume flow still reflects distribution pressure. Constructive setup — key momentum and institutional cues are broadly aligned for continued research.
Setup research
EMCURE — trend, RS & risk snapshot (not a trade recommendation)
Signal · context · invalidation · risk · skip reasons — research only
Positives
Coiled at the pivot — breakout trigger is imminent
- Volume 3.7× the 50-day average
- RS line at new highs — leadership intact
- Handle formed after the prior advance
- Confirmed Stage 2 uptrend
Context & regime
- Market regime Mixed / range-bound
- Trend stage Stage 2 — tradable
- Sector Mid-pack (#20/40)
- Relative strength Leader (RS 81)
- Trend strength Strong (ADX 32)
Negatives
This idea is wrong below ₹1708.0 (9.2% away)
Base / stop support breaks — the swing thesis is wrong below here
- Stop / base low₹1708.0
- Pivot — failure re-entry below₹1830.0
Risk distance
Risk ≈ ₹131.17/share from entry ₹1839.2.
No major skip flags detected from current scanner data.
Setup metrics Base Formation
EMCURE Technical Analysis & Swing Setup
Grouped structure, momentum and risk from the latest base formation scan.
Structure
Momentum
Risk
More scanner fields
EMCURE Support & Resistance Levels
Research chart
Daily price action with pivot, support, and resistance levels from our latest scan, plus relative strength vs Nifty.
Pivot levels, support and resistance are drawn on the price chart. · Research only.
Sector RS rank · latest scan
Loading peer comparison…
Seasonality — monthly returns
How this stock moved month by month over the last ~2 years.
A rough tendency, not a reliable pattern. Research only, not advice.
AI insights
AI Insights
Generated with AIThese insights are AI-generated to support your research process and should not be treated as investment advice or a recommendation to buy or sell securities.
Sign in to unlock AI Insights
Personalised swing trade analysis powered by Gemini AI
Pattern context 52w · setup · flow
52-week range
—Stage-2 ideal band · Early recovery
Pattern highlights
Pattern signals from the latest scan
Smart money flow
Last 60 sessions · accumulation vs distribution
Setup intelligence Overhead · VCP · radar · risk
Overhead supply
Resistance ceiling above current price
Chase / failure risk
Honest read on exhaustion & extended moves
Base / VCP coil
Depth, contractions & pivot distance
Setup quality radar
Shape of the setup in one view
Peer comparison Sector peers
Sector Peer Comparison
Loading sector peers…
EMCURE FAQ Common swing-trading questions
Frequently asked questions about EMCURE
What are the screener observations for EMCURE?
On Swing Edge's swing-setup framework, Emcure Pharmaceuticals Ltd. (EMCURE) currently grades A — high-quality setup. Coiled at the pivot — breakout trigger is imminent. Flagged today. This is educational research, not investment advice.
What are EMCURE's support and resistance levels?
For EMCURE, near-term support sits around ₹1,708.0 (the base/stop zone); overhead resistance is around ₹1,830.0 (the breakout pivot); the next resistance above is ₹2,196.0. This is educational research, not investment advice.
What is the breakout / pivot level for EMCURE?
The breakout pivot for EMCURE is around ₹1,830.0. Price is currently about 2.7% above the pivot. A breakout is typically confirmed on a close above the pivot with above-average volume. This is educational research, not investment advice.
Is EMCURE above its 50-day and 200-day moving averages?
Yes — EMCURE is in a confirmed Stage 2 uptrend, trading above its rising 50- and 200-day moving averages, the zone where swing setups tend to work best. This is educational research, not investment advice.
How strong is EMCURE versus the market (RS rank)?
EMCURE has a relative strength (RS) rank of 81 out of 100 versus the NSE universe, making it a market leader — stronger than most NSE stocks. Trend strength (ADX) reads 32, indicating a strong trend. This is educational research, not investment advice.
Answers are generated from Swing Edge's latest scan data and are for research only — not investment advice.
Prices and day-change figures use the last daily close from scan data dated 2026-06-25 — not live intraday NSE quotes.